In in vitro models, such as MCF7, MDA-MB-231, and SK-BR-3 breast cancer cells, leptin activates signaling pathways that promote proliferation, cell migration, invasion, and epithelial–mesenchymal transition (EMT) [5,6,7]. Here, LEP is linked to breast carcinoma.